Abstract
Estrogen replacement therapy has been shown to attenuate atherogenesis, although the mechanisms for this effect are incompletely defined. Previously, we showed that 17-β estradiol (estradiol) attenuated oxidant stress-induced increases in vascular low density lipoprotein (LDL) accumulation. It was unclear whether estradiol's effect was imparted on the lipoprotein particle or the artery wall. To examine this, we chronically treated rats with the following sex hormones: low estradiol, high estradiol, progesterone, low estradiol + progesterone, placebo, or control. Carotid arteries (n = 8/group) were isolated and perfused with fluorescently labeled LDL. Rates of LDL accumulation were measured before and after treatment with 10 ng/ml tumor necrosis factor-α (TNF) using quantitative fluorescence microscopy. We observed a 50% decrease in basal LDL accumulation rates (P < 0.01) and a 25% decrease in endothelial layer permeability (P < 0.01) in arteries from estradiol-treated animals. There was no effect of hormone replacement on rate of TNF-induced LDL accumulation (P = 0.451), while incubation of LDL with 65 pg/ml estradiol attenuated the TNF effect (P < 0.01). These experiments suggest two independent mechanisms of anti-atherogenic protection by estradiol: 1) decreased endothelial layer permeability; and 2) incorporation of estradiol into the LDL particle and prevention of LDL binding to the artery wall. — Walsh, B. A., A. E. Mullick, C. E. Banka, and J. C. Rutledge. 17β-Estradiol acts separately on the LDL particle and artery wall to reduce LDL accumulation.
Highlights
Estrogen replacement therapy has been shown to attenuate atherogenesis, the mechanisms for this effect are incompletely defined
One of the initial steps in the development of atherosclerosis is the accumulation of low density lipoprotein (LDL) in the artery wall [1]
To determine whether chronic sex hormone administration altered LDL flux in the artery wall, we examined the rate of LDL accumulation under control conditions in vessels from animals undergoing 6 months of hormone treatment
Summary
Estrogen replacement therapy has been shown to attenuate atherogenesis, the mechanisms for this effect are incompletely defined. We showed that 17- estradiol (estradiol) attenuated oxidant stress-induced increases in vascular low density lipoprotein (LDL) accumulation. It was unclear whether estradiol’s effect was imparted on the lipoprotein particle or the artery wall. There was no effect of hormone replacement on rate of TNF-induced LDL accumulation (P ؍0.451), while incubation of LDL with 65 pg/ml estradiol attenuated the TNF effect (P Ͻ 0.01) These experiments suggest two independent mechanisms of anti-atherogenic protection by estradiol: 1) decreased endothelial layer permeability; and 2) incorporation of estradiol into the LDL particle and prevention of LDL binding to the artery wall.— Walsh, B. Antioxidant protection of plasma lipids and vascular wall tissue against oxidative damage could attenuate the development of atherosclerosis.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
